ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACRV Acrivon Therapeutics Inc

7.15
0.685 (10.60%)
29 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Acrivon Therapeutics Inc ACRV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.685 10.60% 7.15 11:00:00
Open Price Low Price High Price Close Price Previous Close
6.29 6.01 7.31 7.15 6.465
more quote information »

Recent News

Date Time Source Heading
28/3/202423:00GLOBEAcrivon Therapeutics Reports Fourth Quarter and Full Year..
07/3/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202408:30GLOBEAcrivon Therapeutics to Present Data at AACR Annual Meeting..
05/3/202400:15EDGAR2Form 8-K - Current report
05/3/202400:00GLOBEAcrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA,..
28/2/202400:00GLOBEAcrivon Therapeutics to Participate in a Panel Discussion at..
17/2/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202407:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202400:27EDGAR2Form 8-K - Current report
09/2/202400:00GLOBEAcrivon Therapeutics Appoints Seasoned Industry Executive..
07/2/202400:00GLOBEAcrivon Therapeutics to Present at the Oppenheimer 34th..
20/1/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202408:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
08/1/202423:28EDGAR2Form 8-K - Current report
05/1/202400:00GLOBEAcrivon Therapeutics to Present at the 42nd Annual J.P...
18/12/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
09/12/202308:21EDGAR2Form 8-K - Current report
02/12/202308:35EDGAR2Form S-3 - Registration statement under Securities Act of..
29/11/202300:58DJNAcrivon Therapeutics Gets FDA's Breakthrough Designation for..
29/11/202300:00GLOBEAcrivon Therapeutics Announces FDA has Granted Breakthrough..
22/11/202300:00GLOBEAcrivon Therapeutics Announces Inducement Grant Under Nasdaq..
17/11/202311:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202311:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202301:12EDGAR2Form 8-K - Current report
10/11/202300:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:01GLOBEAcrivon Therapeutics Reports Third Quarter 2023 Financial..
20/10/202310:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202323:00GLOBEAcrivon Therapeutics Presents Data Demonstrating..
29/9/202309:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202309:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/9/202306:05GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
20/9/202306:32GLOBEAcrivon Therapeutics to Highlight its ACR-368 OncoSignature..
06/9/202307:23EDGAR2Form 8-K - Current report
06/9/202306:05GLOBEAcrivon Therapeutics Announces ACR-2316, a Novel Dual WEE1..
30/8/202322:00GLOBEAcrivon Therapeutics to Participate in Two Investor..
24/8/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202306:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
11/8/202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/8/202321:17EDGAR2Form 8-K - Current report
11/8/202321:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

Delayed Upgrade Clock